Cite
HARVARD Citation
Miura, K. et al. (n.d.). Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy. Leukemia & lymphoma. 57 (6), pp. 1335-1341. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Miura, K. et al. (n.d.). Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy. Leukemia & lymphoma. 57 (6), pp. 1335-1341. [Online].